-+ 0.00%
-+ 0.00%
-+ 0.00%

SKYE BIOSCIENCE - HOLDERS TO RECEIVE CVR FOR 90% OF NIMACIMAB NET PROCEEDS FOR 12 MONTHS POST-CLOSING

Reuters·08/14/2026 13:33:25

Please log in to view news